Dapagliflozin exhibits class I antiarrhythmic effects which suppress action potential formation in human atrial cardiomyocytes

Saved in:
Bibliographic Details
Published in:European heart journal 2022-10, Vol.43 (Supplement_2)
Main Authors: Paasche, A, Wiedmann, F, Javorszky, N, Yesilgoez, B, Blochberger, P, Kraft, M, Frey, N, Schmidt, C
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0195-668X
1522-9645
DOI:10.1093/eurheartj/ehac544.358